Differential effects of BTK inhibitors ibrutinib and zanubrutinib on NK-cell effector function in patients with mantle cell lymphoma

被引：49
|
作者：
Flinsenberg, Thijs W. H. [1 ,2 ]
Tromedjo, Charnelle C. [1 ,2 ]
Hu, Nan [3 ]
Liu, Ye [3 ]
Guo, Yin [3 ]
Thia, Kevin Y. T. [1 ,2 ]
Noori, Tahereh [1 ,2 ]
Song, Xiaomin [3 ]
Aw Yeang, Han X. [1 ,2 ,4 ]
Tantalo, Daniela G. [1 ,2 ]
Handunnetti, Sasanka [5 ,6 ,7 ]
Seymour, John F. [5 ,6 ,7 ]
Roberts, Andrew W. [5 ,6 ,7 ]
Ritchie, David [5 ,6 ,7 ,8 ,9 ]
Koldej, Rachel [5 ,8 ,9 ]
Neeson, Paul J. [1 ,2 ,4 ]
Wang, Lai [3 ]
Trapani, Joseph A. [1 ,2 ,4 ]
Tam, Constantine S. [5 ,6 ,7 ]
Voskoboinik, Ilia [1 ,2 ,4 ]
机构：
[1] Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic, Australia
[2] Peter MacCallum Canc Ctr, Rosie Lew Immunotherapy Program, Melbourne, Vic, Australia
[3] BeiGene LTD, Beijing, Peoples R China
[4] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic, Australia
[5] Univ Melbourne, Fac Med Dent & Hlth Sci, Parkville, Vic, Australia
[6] Peter MacCallum Canc Ctr, Dept Clin Haematol, Melbourne, Vic, Australia
[7] Royal Melbourne Hosp, Melbourne, Vic, Australia
[8] ACRF Translat Res Lab, Parkville, Vic, Australia
[9] Royal Melbourne Hosp, Parkville, Vic, Australia
来源：
HAEMATOLOGICA | 2020年 / 105卷 / 02期
基金：
英国医学研究理事会;
关键词：
D O I：
10.3324/haematol.2019.220590
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E76 / E79
页数：4
相关论文
共 50 条
  • [1] Use of BTK inhibitors with focus on ibrutinib in mantle cell lymphoma: An expert panel opinion statement
    Zinzani, Pier Luigi
    Martelli, Maurizio
    Ferrero, S.
    Gentile, Massimo
    Laurenti, Luca
    Mauro, Francesca Romana
    Sportoletti, Paolo
    Tedeschi, Alessandra
    Varettoni, M.
    Visco, Carlo
    HEMATOLOGICAL ONCOLOGY, 2022, 40 (04) : 518 - 527
  • [2] Zanubrutinib: a new BTK inhibitor for treatment of relapsed/refractory mantle cell lymphoma
    Weaver, A. N.
    Jimeno, A.
    DRUGS OF TODAY, 2020, 56 (08) : 531 - 539
  • [3] Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
    Wang, Michael L.
    Rule, Simon
    Martin, Peter
    Goy, Andre
    Auer, Rebecca
    Kahl, Brad S.
    Jurczak, Wojciech
    Advani, Ranjana H.
    Romaguera, Jorge E.
    Williams, Michael E.
    Barrientos, Jacqueline C.
    Chmielowska, Ewa
    Radford, John
    Stilgenbauer, Stephan
    Dreyling, Martin
    Jedrzejczak, Wieslaw Wiktor
    Johnson, Peter
    Spurgeon, Stephen E.
    Li, Lei
    Zhang, Liang
    Newberry, Kate
    Ou, Zhishuo
    Cheng, Nancy
    Fang, Bingliang
    McGreivy, Jesse
    Clow, Fong
    Buggy, Joseph J.
    Chang, Betty Y.
    Beaupre, Darrin M.
    Kunkel, Lori A.
    Blum, Kristie A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (06): : 507 - 516
  • [4] Advances in the treatment of mantle cell lymphoma with BTK inhibitors
    Shen, Jiwei
    Li, Jiawei
    Yang, Rui
    Wu, Shuang
    Mu, Zhimei
    Ding, Shi
    Zhang, Xinyu
    Duo, Meiying
    Chen, Ye
    Liu, Ju
    LEUKEMIA RESEARCH, 2024, 147
  • [5] Economic Evaluation of Ibrutinib Versus Acalabrutinib Versus Zanubrutinib for Patients with Relapsed or Refractory Mantle Cell Lymphoma
    Alrawashdh, Neda
    McBride, Ali
    Slack, Marion
    Abraham, Ivo
    BLOOD, 2020, 136
  • [6] Relapsed/Refractory Mantle Cell Lymphoma: Beyond BTK Inhibitors
    Burkart, Madelyn
    Karmali, Reem
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (03):
  • [7] Three BTK-Specific Inhibitors, in Contrast to Ibrutinib, Do Not Antagonize Rituximab-Dependent NK-Cell Mediated Cytotoxicity
    Rajasekaran, Narendiran
    Sadaram, Mohith
    Hebb, Jonathan
    Sagiv-Barfi, Idit
    Ambulkar, Sid
    Rajapaksa, Amanda
    Chang, Serena
    Chester, Cariad
    Waller, Erin
    Wang, Lai
    Lannutti, Brian
    Johnson, Dave
    Levy, Ron
    Kohrt, Holbrook E.
    BLOOD, 2014, 124 (21)
  • [8] Cryptococcal meningoencephalitis in patients with mantle cell lymphoma on ibrutinib
    Sun, Kai
    Kasparian, Saro
    Iyer, Swaminathan
    Pingali, Sai Ravi
    ECANCERMEDICALSCIENCE, 2018, 12
  • [9] Novel treatment for mantle cell lymphoma - impact of BTK inhibitors and beyond
    Gribbin, Caitlin
    Chen, Jane
    Martin, Peter
    Ruan, Jia
    LEUKEMIA & LYMPHOMA, 2024, 65 (01) : 1 - 13
  • [10] Responses to BTK inhibitors in mantle cell lymphoma post allogeneic stem cell transplant
    Wharin, S.
    Tsoulkani, A.
    Walter, H.
    Hunter, A.
    Hodgson, K.
    Lewin, R.
    Dyer, M.
    Martin, M.
    Miall, F.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 : 168 - 168
12345